NovaBay Pharmaceuticals, Inc. Total non-current liabilities

Total non-current liabilities of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Total non-current liabilities growth rates and interactive chart.


Highlights and Quick Summary

  • Total non-current liabilities for the quarter ending June 30, 2022 was $2.14 Million (a -5.39% decrease compared to previous quarter)
  • Year-over-year quarterly Total non-current liabilities increased by 214100.0%
  • Annual Total non-current liabilities for 2021 was $10.4 Million (a 11813.79% increase from previous year)
  • Annual Total non-current liabilities for 2020 was $87 Thousand (a -98.09% decrease from previous year)
  • Annual Total non-current liabilities for 2019 was $4.56 Million (a 714.29% increase from previous year)
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Total non-current liabilities of NovaBay Pharmaceuticals, Inc.

Most recent Total non-current liabilitiesof NBY including historical data for past 10 years.

Interactive Chart of Total non-current liabilities of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Total non-current liabilities for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $2.14 $2.26
2021 $10.37 $0.0 $0.01 $0.01 $10.37
2020 $0.09 $0.2 $7.99 $4.34 $0.09
2019 $4.56 $4.84 $4.85 $3.18 $4.56
2018 $0.56 $0.93 $1.22 $1.73 $0.56
2017 $2.51 $3.96 $4.13 $4.02 $2.51
2016 $3.96 $4.7 $5.1 $8.2 $3.96
2015 $5.54 $2.21 $2.51 $2.31 $5.54
2014 $2.34 $3.0 $2.28 $3.07 $2.34
2013 $3.51 $3.76 $2.83 $2.61 $3.51
2012 $2.01 $2.19 $2.72 $3.74 $2.01
2011 $3.78 $3.78

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology